NCT01575288View on ClinicalTrials.gov

Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Vascular Aging
Interventions
DRUG

Placebo

100g maltose 1/day

DRUG

High-dose trehalose

100g 1/day

Trial Locations (1)

80309

University of Colorado, Boulder Clinical Translational Research Center, Boulder

All Listed Sponsors
lead

University of Colorado, Boulder

OTHER

NCT01575288 - Oral Trehalose Therapy to Reverse Arterial Aging in Middle-Aged and Older Adults | Biotech Hunter | Biotech Hunter